E-LIB Suche - Ergebnisse für: Ruane, Peter J.

Vesikari, Timo ; Finn, Adam ; van Damme, Pierre...
Vesikari , T , Finn , A , van Damme , P , Leroux-Roels , I , Leroux-Roels , G , Segall , N , Toma , A , Vallieres , G , Aronson , R , Reich , D , Arora , S , Ruane , P J , Cone , C L , Manns , M , Cosgrove , C , Faust , S N , Ramasamy , M N , Machluf , N , Spaans , J N , Yassin-Rajkumar , B , Anderson , D , Popovic , V , Diaz-Mitoma , F 2021 , ' Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine : A Phase 3 Randomized Clinical Trial ' , JAMA Network Open , vol. 4 , no. 10 , e2128652 , pp. e2128652 . https://doi.org/10.1001/jamanetworkopen.2021.28652. , 2021

Link: https://hdl.handle.net/1..

8

Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccin..:

Vesikari, Timo ; Finn, Adam ; van Damme, Pierre...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511978/. , 2021

Link: http://www.ncbi.nlm.nih...

9

Clinical targeting of HIV capsid protein with a long-acting..:

Link, John O ; Rhee, Martin S ; Tse, Winston C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188729/. , 2020

Link: http://www.ncbi.nlm.nih...

10

1028. Long-term Follow-up After a Switch to Bictegravir, Em..:

Brar, Indira ; Ruane, Peter ; Ward, Douglas...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777514/. , 2020

Link: http://www.ncbi.nlm.nih...

11

Protein O-GlcNAcylation Promotes Trophoblast Differentiatio..:

Ruane, Peter ; Tan, Cheryl M. J ; Adlam, Daman...
Ruane , P , Tan , C M J , Adlam , D , Kimber , S , Brison , D R , Aplin , J & Westwood , M 2020 , ' Protein O-GlcNAcylation Promotes Trophoblast Differentiation at Implantation ' , Cells . https://doi.org/10.3390/cells9102246. , 2020

Link: https://research.manches..

12

Week 96 efficacy and safety results of the phase 3, randomi..:

Eron, Joseph ; Orkin, Chloe ; Cunningham, Douglas...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.antiviral.2019.104543. , 2019

Link: https://amu.hal.science/..

13

Glecaprevir/Pibrentasvir in patients with chronic HCV genot..:

Flamm, Steven ; Mutimer, David ; Asatryan, Armen...
boreal:222229. , 2019

Link: http://hdl.handle.net/20..

14

Week 96 efficacy and safety results of the phase 3, randomi..:

Eron, Joseph ; Orkin, Chloe ; Cunningham, Douglas...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.antiviral.2019.104543. , 2019

Link: https://amu.hal.science/..

15

Glecaprevir/Pibrentasvir in patients with chronic HCV genot..:

Flamm, Steven ; Mutimer, David ; Asatryan, Armen...
boreal:222229. , 2019

Link: http://hdl.handle.net/20..